title: How to evaluate CMV disease in renal transplantation.
authors.affiliation: Department of Immunology, Tehran University of Medical Sciences, Iran.
authors.forename: E
authors.initials: E
authors.lastname: Hashemi
authors.forename: B
authors.initials: B
authors.lastname: Broumand
authors.forename: M R
authors.initials: MR
authors.lastname: Ganji
authors.forename: I
authors.initials: I
authors.lastname: NadJafi
authors.forename: G
authors.initials: G
authors.lastname: Naderi
authors.forename: B
authors.initials: B
authors.lastname: Nikbin
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D015774:Ganciclovir / Q000627:therapeutic use; D006801:Humans; D016030:Kidney Transplantation; D007958:Leukocyte Count; D009504:Neutrophils; D011183:Postoperative Complications
chemical_list: D000998:Antiviral Agents; D015774:Ganciclovir